Travere Therapeutics
San Diego · Founded 2008
About Travere Therapeutics
Travere Therapeutics is advancing therapeutic candidates for rare disorders in nephrology, hepatology and metabolism; sponsoring no-cost genetic testing aimed at improving the diagnostic odyssey for children born with cholestasis; partnering with patient advocacy organizations to meet the diverse needs of patients and their families; and ensuring broad access and education for its FDA-approved therapies.
Company Facts
- Founded: 2008
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $1.1B
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2024)
- Ticker: nasdaq:TVTX
- Website: travere.com
- Phone: (646) 564-3680
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/travere-therapeutics-54774 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.